SUMMARY Eight commercial topical anaesthetic preparations were tested for their ability to inhibit microbial growth in vitro by incubating serial dilutions with each of 4 micro-organisms. In addition comeas of mice were infected with Staphylococcus aureus, and the effect of the anaesthetics on isolation rates of bacteria was investigated. The preparations were shown to have a wide range of antimicrobial activity, correlating both with the active agents and the preservatives. We suggest that some preparations are unsuitable for use prior to collection of specimens from human corneal ulcers.
The successful management of corneal infection depends on the early commencement of specific antimicrobial chemotherapy. Since this requires the prompt identification of causative micro-organisms, the procedure for specimen collection must ensure no loss of viability of these agents.
Material for culture from infected comeas is often collected after application of a topical anaesthetic. Usually only a small amount of material is obtained, giving a light growth of bacteria or fungi. An anaesthetic preparation with considerable antimicrobial activity might lead to a dangerous false negative culture result.
A range of topical preparations is available to ophthalmologists; multidose containers ofanaesthetic and preservative and single-dose vials containing the anaesthetic agent only. The antimicrobial activities of the anaesthetic agents and preservatives have been determined separately in vitro, '-3 and several clinical trials of anaesthetics during bronchial and odontological procedures have been reported. 4 We determined the antimicrobial activities of 8 commercially available topical anaesthetics in vitro, using a minimum inhibitory concentration (MIC) assay and used a mouse model of corneal infection to test the effect of the preparations on the recovery of viable bacteria. 
364
Pseudomonas aeruginosa, Streptococcus pneumoniae, and Candida albicans were selected, as these organisms are commonly found in infected corneas. Single colonies were cultured overnight in MuellerHinton broth (Staph. aureus and Ps. aeruginosa), Todd-Hewitt broth (Str. pneumoniae), or Sabouraud broth (C. albicans).
Eight commercial preparations were assayed. These are set out in Table 1 .
The microbial suspensions were subcultured and reincubated for 3 hours. Serial 2-fold dilutions of the anaesthetic preparations were made in the appropriate broth in microtitre trays. An equal volume of suspension (50 ,1l) containing 10' organisms in the log phase of growth was added to each well, and the trays were incubated for 18 hours at 37°C. Growth of organisms was defined as the appearance in a well of an aggregate larger than 2 mm in diameter. Loopfuls from the no-growth wells were plated out on to blood agar to give the maximum microbicidal dilution.
IN-VIVO ASSAY
The animals chosen were Fl (Balb/cxC57B1) mice. A Staph. aureus strain (penicillin-resistant, phage type 55/71) isolated from a human corneal ulcer was used to infect the mice.
The animals were given ketamine intraperitoneally (4 mg). Both corneas of each mouse were incised with a scalpel blade and keratome, and several drops of a concentrated (10"/ml) bacterial suspension were dropped onto the cornea. 24 hours later 80% of the eyes had developed keratitis, and these were used in the test. The eye was prolapsed and a sterile (Table 3) are expressed as drug for each organism are set out in Table 2 . These the mean (x) of the difference in colony counts expressions are more suitable than concentrations between the scrapings prior to and after application when we are dealing with mixtures. Each value was of topical anaesthetic, i.e., derived from testing 4 different isolates in duplicate. Variation between isolates of one organism rarely x=logo (counts #1+1)-log,0 (counts #2+1) exceeded one well. Novesine was generally the most lethal preparation, followed by Alcaine, Ophthaine, Novesine reduced the counts by over 1 log, saline had benoxinate is required to inhibit these 3 organisms. Also our streptococci are more sensitive to amethocaine (0015% versus 0-5% for inhibition) and our candidas less sensitive to amethocaine (0-167% versus 0-015%). These inconsistencies may reflect different strains, media, and anaesthetic preparations, since the Minims contain stabiliser.
A number of factors could influence the effect of the anaesthetics on organisms in human corneas, including total dosage, dilution by tears, the number of organisms present, and the efficiency of absorption into the diseased area of both the anaesthetic agents and preservatives. From the mouse studies we find that the time the drug is on the eye before culturing is important: counts decrease over the first 10 minutes.
Novesine significantly reduces the isolation rate of Staph. aureus from corneal ulcers in mice, and this preparation has a high anti-microbial activity in vitro. It would seem that Novesine should not be placed on a patient's eye prior to collecting material for microbiological study. Ophthetic, Ophthaine, and Alcaine, and any other topical anaesthetic containing benzalkonium chloride at 0-01%, also appear to have an unacceptably high level of antimicrobial activity in this instance.
From these results and previous reports it would appear that Minims benoxinate is the preferred drug for obtaining material for culture. It is also unlikely that Minims amethocaine, Decicain, containing chlorobutanol, or Xylocaine Ophthalmic, containing benzalkonium chloride at low concentration, have any effect on isolation rates of organisms from comeas if not left on the eye for more than 2 or 3 minutes.
It should be remembered that infected corneas are relatively insensitive, and collections can often be made without the use of a local anaesthetic. When this is not possible, any reduction in the number of viable organisms recovered from a cornea due to the anaesthetic agent is probably counterbalanced by the increased amount of material obtainable from an anaesthetised eye. The anaesthetic preparation we choose to use should not compromise our chance of recovering the causative agent. 
